Georgia Bio and Brex Partner to Enhance Member Benefits
Exciting news for Georgia Bio members! The Georgia Bio Brex program, established through our partnership with BIO, has been expanded to provide even greater benefits for your organization. On top of the existing corporate credit card with its industry-specific rewards, members can now access savings on business accounts, spend management software, and travel management solutions.
Upgrade Your Financial Toolkit Learn more and upgrade at bio.org/save/brex
Enhanced Benefits at a Glance
- High-Yield Business Accounts: Enjoy industry-leading yields, effortless wire transfers, and global ACH capabilities with your Brex business account. Brex partner banks offer a competitive 4.92% APY with same-day liquidity, all FDIC-insured up to $6 million. Additionally, you can make free bill payments, international ACH transfers, issue checks, and send wires. Brex accounts can even accommodate up to 240 unique account numbers.
- Scalable Spend Management:
Brex’s advanced spend management system empowers you to manage your company’s spending and close the books in real-time. Features include:
- Budgets with automated enforcement of spending policies
- Streamlined employee reimbursements with advanced approval workflows
- Customizable approval processes to automate in-policy spending approvals
- Global reimbursements in local currencies and accounts
- Automatic receipt generation, eliminating the need for manual receipt collection and expense reports
- Integration with thousands of tools to streamline workflows
- Comprehensive Travel & Expense Management:
Simplify travel and group event management with a unified solution encompassing travel booking, event coordination, expense tracking, corporate cards, and reimbursements. Brex’s travel and expense features include:
- Consolidated booking for flights, hotels, and car rentals
- Integrated travel policy enforcement
- Access to a vast, unbiased global travel inventory
- Pre-negotiated discounts
- Tools to achieve 100% travel program adoption within your organization
Georgia Bio’s commitment to empowering its members is stronger than ever. With the enhanced Brex program, you can streamline financial processes, gain real-time insights into spending, and optimize travel management, all while earning industry-leading returns on your business accounts.
Georgia Life Sciences leads effort to establish bipartisan caucus focused on advancing the state’s growing life sciences economy
A skilled workforce is the engine that will drive growth across America’s biotechnology industry, and Atlanta has built multi-faceted training programs that are developing and sustaining the talent pipeline for everything from advanced laboratory research to industrial biomanufacturing.
On March 12, 2026, Augusta, Georgia served as the setting for an important conversation about the future of American biotechnology and manufacturing. Manus welcomed members of the U.S. National Security Commission on Emerging Biotechnology (NSCEB) to its Augusta BioFacility to highlight how advanced biomanufacturing is strengthening U.S. supply chain resilience and supporting the growing bioeconomy. During the visit, Manus unveiled a significant expansion of its 44-acre Augusta BioFacility, increasing domestic capacity to produce critical biobased ingredients. The expansion further positions Georgia as a key hub for advanced biomanufacturing and demonstrates the growing role of biotechnology in strengthening national economic and supply chain security. Commission members met with leaders from industry, government, and academia to discuss strategies for scaling manufacturing infrastructure, strengthening resilient supply chains, and preparing the workforce needed to support the next generation of the U.S. bioeconomy. The visit also included conversations with Manus employees about the practical realities of building and operating advanced biomanufacturing facilities in the United States. The Augusta site has become one of the largest advanced biomanufacturing facilities in the country, producing a growing portfolio of bioalternatives at industrial scale. Among these products is high-purity Reb M, recently launched as Yume™ M Stevia Sweetener , supported by an all-Americas supply chain. “As we scale the Manus bioalternatives platform, Augusta has become a powerful example of what the modern U.S. bioeconomy looks like in practice,” said Manus Founder and CEO Ajikumar Parayil. The visit underscores Georgia’s expanding leadership in life sciences manufacturing and highlights how regional ecosystems can help advance U.S. leadership in biotechnology and biomanufacturing. Learn more about the expansion and visit: Manus welcomes U.S. National Security Commission on Emerging Biotechnology to unveil major Augusta BioFacility expansion Growing Georgia Biomanufacturing Industry Transforming American Industrial Strength
